Barclays PLC Increases Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Barclays PLC raised its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 209.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 166,492 shares of the company’s stock after acquiring an additional 112,667 shares during the quarter. Barclays PLC’s holdings in HealthEquity were worth $13,628,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the business. Public Employees Retirement System of Ohio boosted its holdings in shares of HealthEquity by 5.6% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 91,754 shares of the company’s stock valued at $7,510,000 after buying an additional 4,878 shares in the last quarter. Main Management ETF Advisors LLC purchased a new stake in HealthEquity in the third quarter valued at $889,000. Zacks Investment Management boosted its stake in HealthEquity by 10.8% in the third quarter. Zacks Investment Management now owns 31,456 shares of the company’s stock valued at $2,575,000 after acquiring an additional 3,059 shares in the last quarter. DF Dent & Co. Inc. grew its holdings in shares of HealthEquity by 26.4% during the third quarter. DF Dent & Co. Inc. now owns 296,579 shares of the company’s stock worth $24,275,000 after purchasing an additional 61,864 shares during the last quarter. Finally, EP Wealth Advisors LLC purchased a new position in shares of HealthEquity during the third quarter worth about $340,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Barrington Research upped their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Monday, December 2nd. Royal Bank of Canada increased their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Mizuho began coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. Finally, BTIG Research lifted their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and an average price target of $110.71.

HealthEquity Trading Up 0.7 %

NASDAQ HQY opened at $95.62 on Monday. The company has a quick ratio of 4.10, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $8.29 billion, a P/E ratio of 87.72, a P/E/G ratio of 1.10 and a beta of 0.55. HealthEquity, Inc. has a 52-week low of $62.10 and a 52-week high of $105.82. The firm has a 50-day moving average price of $94.06 and a 200 day moving average price of $84.26.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now directly owns 66,469 shares in the company, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the company’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the transaction, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. This trade represents a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 43,786 shares of company stock worth $4,140,387. Company insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.